We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
PREMIER Biosoft International Releases SimGlycan® 2.92 with Support for Multi Stage Mass Spectrometry Data Analysis
Product News

PREMIER Biosoft International Releases SimGlycan® 2.92 with Support for Multi Stage Mass Spectrometry Data Analysis

PREMIER Biosoft International Releases SimGlycan® 2.92 with Support for Multi Stage Mass Spectrometry Data Analysis
Product News

PREMIER Biosoft International Releases SimGlycan® 2.92 with Support for Multi Stage Mass Spectrometry Data Analysis


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "PREMIER Biosoft International Releases SimGlycan® 2.92 with Support for Multi Stage Mass Spectrometry Data Analysis"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

PREMIER Biosoft International has announced the worldwide release of version 2.92 of its MS data analysis tool, SimGlycan®. The program now includes comprehensive support to perform multi-stage/sequential mass spectrometry (MSn) data analysis which involves re-fragmentation of product ions.

Multi-stage mass analysis provides structural information that is useful in structure elucidation of metabolites, glycopeptides and glycans. It aids in discrimination of glycans having similar characteristic fragment ions at MS/MS level. It resolves heterogeneity of carbohydrate distribution and branching pattern of complex glycans such as isobaric isomers.

“Multi-stage mass spectrometry has become a powerful procedure for the investigation of protein glycosylation and therefore, crucial for biopharmaceuticals,” said Kay Brown, V.P. Business Development and Marketing.
Advertisement